Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX6BPT
|
||||
| Drug Name |
2-(p-tolyl(3-(trifluoromethyl)phenyl)methylene)hydrazinecarbothioamide
|
||||
| Synonyms |
CHEMBL407264
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C16H14F3N3S
|
||||
| Canonical SMILES |
Cc1ccc(cc1)\\C(=N\\NC(=S)N)\\c2cccc(c2)C(F)(F)F
|
||||
| InChI |
InChI=1S/C16H14F3N3S/c1-10-5-7-11(8-6-10)14(21-22-15(20)23)12-3-2-4-13(9-12)16(17,18)19/h2-9H,1H3,(H3,20,22,23)/b21-14-
|
||||
| InChIKey |
CTYIIVFLDQCJPG-STZFKDTASA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin L | Target Info | [1587926] | ||
| Cathepsin B | Target Info | [1587926] | |||
| Reactome | Endosomal/Vacuolar pathway | ||||
| Collagen degradation | |||||
| Degradation of the extracellular matrix | |||||
| Trafficking and processing of endosomal TLR | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentationR-HSA-1442490:Collagen degradation | |||||
| MHC class II antigen presentation | |||||
| WikiPathways | Primary Focal Segmental Glomerulosclerosis FSGS | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.